Insider Trading & Ownership - Lynx1 Capital Management LP

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Lynx1 Capital Management LP
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-12-27
Purchase
2024-12-31
4:05 pm
Passage BIO Inc. PASG Lynx1 Capital Management LP
Nichols Weston
10% Owner
373,645 $0.6451 $241,038 9,256,953
(Indirect)
View
2024-12-12
Purchase
2024-12-16
4:26 pm
TScan Therapeutics Inc. TCRX Lynx1 Capital Management LP
Nichols Weston
10% Owner
131,800 $2.9269 $385,769 5,357,347
(Indirect)
View
2024-11-25
Purchase
2024-11-27
6:11 pm
Passage BIO Inc. PASG Lynx1 Capital Management LP
Nichols Weston
10% Owner
456,353 $0.62346 $284,520 8,883,308
(Indirect)
View
2024-11-15
Purchase
2024-11-19
4:26 pm
TScan Therapeutics Inc. TCRX Lynx1 Capital Management LP
Nichols Weston
10% Owner
947 $4.3442 $4,114 5,225,547
(Indirect)
View
2023-05-31
Sale
2023-06-02
5:35 pm
TScan Therapeutics Inc. TCRX Lynx1 Capital Management LP
Nichols Weston
10% Owner
25,400 $2.5178 $63,953 5,224,600
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing

Ownership
2024-08-09
5:11 pm
N/A
N/A
Passage BIO Inc. PASG Lynx1 Capital Management LP
Nichols Weston
10% Owner
0 $0 8,426,955
(Indirect)
View

Ownership
2023-06-02
5:33 pm
N/A
N/A
TScan Therapeutics Inc. TCRX Lynx1 Capital Management LP
Nichols Weston
10% Owner
0 $0 5,250,000
(Indirect)
View